Daiki Sakai

405 total citations
40 papers, 260 citations indexed

About

Daiki Sakai is a scholar working on Ophthalmology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Daiki Sakai has authored 40 papers receiving a total of 260 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Ophthalmology, 12 papers in Molecular Biology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Daiki Sakai's work include Retinal Diseases and Treatments (10 papers), Retinal Development and Disorders (9 papers) and Glaucoma and retinal disorders (6 papers). Daiki Sakai is often cited by papers focused on Retinal Diseases and Treatments (10 papers), Retinal Development and Disorders (9 papers) and Glaucoma and retinal disorders (6 papers). Daiki Sakai collaborates with scholars based in Japan, Germany and United Kingdom. Daiki Sakai's co-authors include Hiroshi Tomita, Makoto Nakamura, Akiko Maeda, Yasuo Kurimoto, Catherine F. Carter, Steven V. Ley, Heiko Lange, Ian R. Baxendale, Yasuhiko Hirami and Masayo Takahashi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Advanced Drug Delivery Reviews and Journal of The Electrochemical Society.

In The Last Decade

Daiki Sakai

34 papers receiving 253 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daiki Sakai Japan 9 90 74 48 44 42 40 260
Motohiro Kamei Japan 8 193 2.1× 87 1.2× 76 1.6× 12 0.3× 16 0.4× 23 323
Michele Oneto Italy 13 177 2.0× 38 0.5× 38 0.8× 173 3.9× 13 0.3× 20 511
Limei Zhang China 12 103 1.1× 101 1.4× 88 1.8× 24 0.5× 9 0.2× 36 347
Samuel A. Minaker Canada 9 125 1.4× 102 1.4× 70 1.5× 17 0.4× 76 1.8× 19 317
Po‐Yi Lee Taiwan 9 33 0.4× 44 0.6× 40 0.8× 42 1.0× 13 0.3× 33 338
Andreas A. Thaer Germany 6 116 1.3× 78 1.1× 170 3.5× 70 1.6× 10 0.2× 8 401
Zhihong Ke China 11 157 1.7× 8 0.1× 49 1.0× 7 0.2× 42 1.0× 31 326
Anna‐Kaisa Rimpelä Finland 9 133 1.5× 130 1.8× 64 1.3× 12 0.3× 8 0.2× 13 288
Joel Gilmore Australia 8 49 0.5× 6 0.1× 17 0.4× 32 0.7× 12 0.3× 10 293

Countries citing papers authored by Daiki Sakai

Since Specialization
Citations

This map shows the geographic impact of Daiki Sakai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daiki Sakai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daiki Sakai more than expected).

Fields of papers citing papers by Daiki Sakai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daiki Sakai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daiki Sakai. The network helps show where Daiki Sakai may publish in the future.

Co-authorship network of co-authors of Daiki Sakai

This figure shows the co-authorship network connecting the top 25 collaborators of Daiki Sakai. A scholar is included among the top collaborators of Daiki Sakai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daiki Sakai. Daiki Sakai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sakai, Daiki, et al.. (2025). hPSC-based treatment of retinal diseases – Current progress and challenges. Advanced Drug Delivery Reviews. 221. 115587–115587. 1 indexed citations
2.
Mizobuchi, Kei, Takaaki Hayashi, Koji Tanaka, et al.. (2024). Genetic and Clinical Features of ABCA4-Associated Retinopathy in a Japanese Nationwide Cohort. American Journal of Ophthalmology. 264. 36–43. 2 indexed citations
3.
Sakai, Daiki, Tadao Maeda, Midori Yamamoto, et al.. (2024). Relationship between residual visual field and full-field stimulus testing in patients with late-stage retinal degenerative diseases. Scientific Reports. 14(1). 2793–2793. 1 indexed citations
4.
5.
Matsuyama, Take, Tadao Maeda, Seiji Takagi, et al.. (2023). Detailed Evaluation of Chromatic Pupillometry and Full-Field Stimulus Testing to Assess Ultralow Vision in Retinitis Pigmentosa. SHILAP Revista de lepidopterología. 3(4). 100328–100328. 5 indexed citations
6.
Sakai, Daiki, M. Hiraoka, Satoshi Yokota, et al.. (2023). Genotype and phenotype characteristics of RHO-associated retinitis pigmentosa in the Japanese population. Japanese Journal of Ophthalmology. 67(2). 138–148. 9 indexed citations
7.
Yamakawa, T, Tatsuya Miyamoto, Daiki Sakai, & Hiroshi Okamoto. (2023). Dynamical aspects of excitonic Floquet states generated by a phase-locked mid-infrared pulse in a one-dimensional Mott insulator. New Journal of Physics. 25(9). 93044–93044. 4 indexed citations
8.
Sakai, Daiki, et al.. (2022). Comparison of the Accuracy of Intraoperative Aberrometry in Intraocular Lens Implantation Between Myopic Eyes with Emmetropia and Myopia Targets. SHILAP Revista de lepidopterología. 3 indexed citations
9.
Yamakawa, T, et al.. (2022). Phonon-dressed states in an organic Mott insulator. Communications Physics. 5(1). 6 indexed citations
10.
Sakai, Daiki, Satoshi Yokota, Akiko Maeda, et al.. (2022). Ocular biometry with swept-source optical coherence tomography-based optical biometer in Japanese patients with EYS-related retinitis pigmentosa: a retrospective study. BMC Ophthalmology. 22(1). 51–51. 2 indexed citations
11.
Sakai, Daiki, Satoshi Yokota, Makoto Nakamura, & Yasuo Kurimoto. (2022). One-year outcomes and predictable factors for microhook ab interno trabeculotomy. International Journal of Ophthalmology. 15(4). 598–603. 1 indexed citations
12.
Sakai, Daiki, Shogo Yamamoto, Fumitaka Hirose, et al.. (2022). Ten-year outcomes of cataract surgery for glaucoma management in patients with primary angle-closure disease. Japanese Journal of Ophthalmology. 67(2). 129–137. 5 indexed citations
13.
Sakai, Daiki, Seiji Takagi, Midori Yamamoto, et al.. (2022). Retinal pigment epithelium melanin imaging using polarization-sensitive optical coherence tomography for patients with retinitis pigmentosa. Scientific Reports. 12(1). 7115–7115. 8 indexed citations
14.
Sakai, Daiki, Yasuhiko Hirami, Makoto Nakamura, & Yasuo Kurimoto. (2021). Accuracy of Intraocular Lens Power Calculation Formulas in Myopic Eyes with Target Refractions of Emmetropia and Intentional Myopia. Clinical ophthalmology. Volume 15. 4535–4541. 2 indexed citations
15.
Sakai, Daiki, Wataru Matsumiya, Sentaro Kusuhara, & Makoto Nakamura. (2021). Factors associated with the development of ocular candidiasis and ocular prognosis with echinocandin therapy for candidemia. Journal of Ophthalmic Inflammation and Infection. 11(1). 17–17. 11 indexed citations
16.
Sakai, Daiki, Hisanori Imai, & Makoto Nakamura. (2021). Multiple Intravitreal Liposomal Amphotericin B for a Case of <b><i>Candida glabrata</i></b> Endophthalmitis. Case Reports in Ophthalmology. 12(2). 485–491. 4 indexed citations
17.
Sakai, Daiki, Wataru Matsumiya, Sentaro Kusuhara, & Makoto Nakamura. (2020). The choroidal structure changes in a case with hypertensive choroidopathy. American Journal of Ophthalmology Case Reports. 18. 100710–100710. 2 indexed citations
18.
Sakai, Daiki, et al.. (2020). LABOR SAVING AND OPTIMIZATION OF 3D IMAGE ANALYSIS FOR FLOATING BODY MOTION MEASUREMENT. Journal of Japan Society of Civil Engineers Ser B3 (Ocean Engineering). 76(2). I_672–I_677.
19.
Sakai, Daiki, et al.. (2020). A STUDY ON DAMAGE REDUCTION MEASURES FOCUSING ON RUBBLE MOUND DURING CONSTRUCTION. Journal of Japan Society of Civil Engineers Ser B3 (Ocean Engineering). 76(2). I_522–I_527.
20.
Fukunaga, Kenji, Daiki Sakai, Kazutoshi Watanabe, et al.. (2015). Discovery of novel 2-(alkylmorpholin-4-yl)-6-(3-fluoropyridin-4-yl)-pyrimidin-4(3H)-ones as orally-active GSK-3β inhibitors for Alzheimer’s disease. Bioorganic & Medicinal Chemistry Letters. 25(5). 1086–1091. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Motohiro Kamei Breakdown of academic impact, for papers by Michele Oneto Breakdown of academic impact, for papers by Limei Zhang Breakdown of academic impact, for papers by Samuel A. Minaker Breakdown of academic impact, for papers by Po‐Yi Lee Breakdown of academic impact, for papers by Andreas A. Thaer Breakdown of academic impact, for papers by Zhihong Ke Breakdown of academic impact, for papers by Anna‐Kaisa Rimpelä Breakdown of academic impact, for papers by Joel Gilmore
Rankless by CCL
2026